Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Methods × Dermatologic × 90 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 17 Gastrointestinal 13 Thoracic 10 Genitourinary 7 Other solid neoplasm 6 Tumor-Agnostic 4 Other hematologic neoplasm 4 Gynecologic 4 Other 2 Lymphoid 2 Dermatologic 1 CNS 1

Conditions

Uveal Melanoma 1

Interventions

pembrolizumab 74 Nivolumab 69 Ipilimumab 36 Specimen Handling 28 Cyclophosphamide 26 Magnetic Resonance Spectroscopy 23 Biopsy 20 fludarabine 18 cemiplimab 17 trametinib 15 relatlimab 15 binimetinib 14 fludarabine phosphate 11 avelumab 11 Opdualag 11 encorafenib 10 Radiosurgery 10 Immunoglobulin G 10 dabrafenib 9 aldesleukin 9 Interleukin-2 9 Disulfides 9 CTLA-4 Antigen 9 atezolizumab 8 Paclitaxel 7 Blood Specimen Collection 7 tebentafusp 6 X-Rays 6 Standard of Care 6 Carboplatin 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06075589 2026-03-19

Psychoeducation for Uveal Melanoma

Jonsson Comprehensive Cancer Center

Phase NA Active not recruiting

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡